MiniMed Group, a subsidiary of Medtronic MDT-0.23%decrease; red down pointing triangle, is looking to spin itself off as an independent company via an initial public offering. The company, which makes ...

As Medtronic begins rolling out a recently FDA-cleared diabetes management system combining its MiniMed 780G insulin pump and Abbott’s Instinct glucose sensor, the medtech giant has launched a new ...

Dec 19 (Reuters) - Medtronic's (MDT.N), opens new tab MiniMed Group filed for a U.S. initial public offering on Friday, as the medical device maker moves ahead with the spin-off of its diabetes ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Medtronic had said earlier this ...

Better devices and changes in implant depth have likely led to fewer LBBBs over time, but the issue needs continued attention ...

Medtronic PLC (Symbol: MDT) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 2.9% yield, as well as a ...

Medtronic plc (NYSE:MDT) is one of the best healthcare AI stocks to buy now. On December 4, Stifel reaffirmed its Hold rating on Medtronic plc (NYSE:MDT), along with a $105 price target. This action ...

WASHINGTON (AP) — The Supreme Court on Tuesday refused to allow the Trump administration to deploy National Guard troops in the Chicago area to support its immigration crackdown. The justices declined ...

The Supreme Court on Tuesday ruled President Trump may not deploy the National Guard to the Chicago area for now amid his push for military troops to patrol the streets of Democratic-led cities, a ...

The Supreme Court’s decision potentially marks a pivotal moment in the ongoing debate over federal authority in domestic law enforcement. The order could shape future conflicts over the balance of ...

Dec 19 (Reuters) - Medtronic's MiniMed Group filed for an initial public offering in the United States on Friday, as the medical device maker moves ahead with the spin-off of its diabetes business.